Baxter outlines 2026 EPS target of $1.85-$2.05 and signals flat organic sales as company pursues turnaround
Source: SeekingAlpha
2026-02-12 13:15:35 ET
More on Baxter
- Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript
- Baxter International Inc. 2025 Q4 - Results - Earnings Call Presentation
- Baxter International: Transition Year With No Immediate Catalysts
- Baxter slips following Q4 bottom line miss, weak 2026 EPS guidance
- Baxter Non-GAAP EPS of $0.44 misses by $0.10, revenue of $2.97B beats by $150M
Read the full article on Seeking Alpha
For further details see:
Baxter outlines 2026 EPS target of $1.85–$2.05 and signals flat organic sales as company pursues turnaround
Baxter International Inc.
NASDAQ: BAX
BAX Trading
-2.09% G/L:
$17.53 Last:
4,405,905 Volume:
$17.75 Open:
BAX Latest News
March 05, 2026 08:30:00 am
Bloomberg 500 (B500) Index Adds Eleven Securities Following March Reconstitution
February 16, 2026 01:08:46 pm
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment
BAX Stock Data
$11,388,906,360
513,027,693
0.04%
338
N/A
Medical Equipment & Supplies
Healthcare
US
Deerfield
